Glucosamine

This class action alleges that the defendants manufactured and sold products labeled as containing glucosamine sulfate, but which in fact did not contain any glucosamine sulfate at all.

Contested Certification

On April 21-23, 2021, Class Counsel appeared before the Court to seek certification of the action against Jamieson Pharmaceuticals Ltd. (“Jamieson”), WN Pharmaceuticals Ltd. (“WN”) and Natural Factors Nutritional Products Limited (“Natural Factors”).

At thattime, the plaintiff did not seek to certify the action against the defendant pharmacies and retailers.

On July 16, 2021, the Court granted the plaintiff’s request to certify the action against WN and Natural Factors but did not certify the case against Jamieson. The Court allowed the plaintiff to file supplemental evidence in support of her case against Jamieson.

On November 1, 2021, the Court granted the plaintiff’s request to certify the action against Jamieson as well.

A copy of the Supplemental Certification Reasons is located under the “Important Documents” heading.

Settlement Approval

A settlement has been reached on a national level with Vita Health Products Inc. and Sisu, Inc. (the “Vita/Sisu Settlement Agreement”). The Vita/Sisu Settlement Agreement was approved by the Court on June 1, 2021.

For more information please contact reception at (604) 689-7555 or by email at [email protected].

Important Documents:

• Notice of Civil Claim
• Vita/Sisu Settlement Agreement
• Notice (Vita/Sisu Settlement Approval Hearing) – English
• Notice (Vita/Sisu Settlement Approval Hearing) – French
• Reasons re: Certification
• Supplemental Certification Reasons
• Reasons for Judgement re: Vita-Sisu Settlement 

Glucosamine - Status Updates:

Glucosamine Class Action: Certification - View

Glucosamine Class Action Certification - View